Papillomavirus Infections
"Papillomavirus Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.
| Descriptor ID |
D030361
|
| MeSH Number(s) |
C02.256.650 C02.928.725
|
| Concept/Terms |
Papillomavirus Infections- Papillomavirus Infections
- Papillomavirus Infection
- HPV Infection
- HPV Infections
- Human Papillomavirus Infection
- Human Papillomavirus Infections
- Papillomavirus Infection, Human
- Papillomavirus Infections, Human
|
Below are MeSH descriptors whose meaning is more general than "Papillomavirus Infections".
Below are MeSH descriptors whose meaning is more specific than "Papillomavirus Infections".
- Papillomavirus Infections
- Warts
This graph shows the total number of publications written about "Papillomavirus Infections" by people in this website by year, and whether "Papillomavirus Infections" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 | | 2000 | 1 | 0 | 1 | | 2002 | 1 | 1 | 2 | | 2003 | 2 | 0 | 2 | | 2004 | 4 | 0 | 4 | | 2005 | 1 | 0 | 1 | | 2006 | 3 | 0 | 3 | | 2007 | 5 | 0 | 5 | | 2008 | 5 | 0 | 5 | | 2009 | 5 | 0 | 5 | | 2010 | 7 | 1 | 8 | | 2011 | 11 | 2 | 13 | | 2012 | 11 | 0 | 11 | | 2013 | 11 | 3 | 14 | | 2014 | 13 | 0 | 13 | | 2015 | 9 | 4 | 13 | | 2016 | 9 | 4 | 13 | | 2017 | 12 | 3 | 15 | | 2018 | 14 | 4 | 18 | | 2019 | 16 | 3 | 19 | | 2020 | 12 | 1 | 13 | | 2021 | 10 | 2 | 12 | | 2022 | 17 | 1 | 18 | | 2023 | 14 | 0 | 14 | | 2024 | 15 | 2 | 17 | | 2025 | 14 | 2 | 16 |
To return to the timeline, click here.
Below are the most recent publications written about "Papillomavirus Infections" by people in Profiles.
-
Saxena K, Dempsey A, Verma RP, Martinez R, Schmier JK, Zimet GD. Parental acceptance of HPV vaccinations at ages 9-10 in the United States. Hum Vaccin Immunother. 2025 Dec; 21(1):2592432.
-
Saxena K, Dempsey A, Verma RP, Schmier JK, Kamat S, Zimet GD. Potential acceptance of HPV vaccination at ages 9-10 in the United States among parents of HPV vaccine-naïve children. Hum Vaccin Immunother. 2025 Dec; 21(1):2578906.
-
Kaplan C, Crane L, Collins A, Parker RL, Orso R, McNicholas C, Sutton E, Memmel L, Conageski C, Hwang Y, Kuroki L, Coleman J, Sheth SS, Harshberger K, Jennings A, Aviki E, Harper D, Mukherjee M, Hibler K, Fitzpatrick MB. At-home self-collection device offers an effective and preferred method to engage high BMI women in cervical cancer screening: method comparison study. Arch Gynecol Obstet. 2025 Dec; 312(6):2043-2051.
-
Befano B, Kalpathy-Cramer J, Egemen D, Inturrisi F, Jeronimo J, Rodríguez AC, Campos N, Cremer M, Ribeiro A, Ajenifuja KO, Goldstein A, Haider A, Yeates K, Madeleine M, Norris T, Figueroa J, Alfaro K, Raiol T, Adepiti C, Norman J, Chilinda GK, Mchome B, Donastorg Y, Dlamini X, Conzuelo G, Banjo AA, Chone P, Mremi A, Benitez A, Rosberger Z, Vantha T, Prieto-Egido I, Boyd-Morin J, Clark C, Kinder S, Wentzensen N, Desai K, Perkins R, de Sanjosé S, Schiffman M. Initial evaluation of a new cervical screening strategy combining human papillomavirus genotyping and automated visual evaluation: the Human Papillomavirus-Automated Visual Evaluation Consortium. J Natl Cancer Inst. 2025 Oct 01; 117(10):2124-2129.
-
Saxena K, Dempsey A, Verma RP, Martinez R, Schmier JK, Zimet GD. Healthcare provider perspectives on HPV vaccinations at ages 9-10 in the United States. Hum Vaccin Immunother. 2025 Dec; 21(1):2561455.
-
O'Leary ST, Skenadore A, Mosley BS, Severson R, Rice JD, Simpson MJ, Brewer SE. Boot camp translation: A novel method to increase human papillomavirus (HPV) vaccination uptake. Vaccine. 2025 Sep 17; 63:127683.
-
Liu H, Yu L, Majerciak V, Meyer TJ, Yi M, Johnson PF, Cam M, Lowy DR, Zheng ZM. The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling in human papillomavirus type 16-infected cervical cancer cells. Elife. 2025 Aug 29; 13.
-
Le PN, Keysar SB, Miller B, Morton JJ, Chimed TS, Alzofon N, Nieto C, Davies KD, Thomas CM, Weaver AN, Jimeno A. Improved Methods for the Stable Generation of Human Papillomavirus-Driven Head and Neck Cancer Cell Lines. Mol Carcinog. 2025 Nov; 64(11):1813-1822.
-
Tietbohl CK, Gurfinkel D, Duran D, Saville A, Clark E, O'Leary S, Albertin C, Beaty B, Vangala S, Szilagyi PG, Kempe A. Feasibility and Acceptability of Recommending HPV Vaccine at Ages 9-10 Years. Pediatrics. 2025 Jul 01; 156(1).
-
Ciemins EL, Rooney A, Yaun JA, Saxena K, Schmier JK, Dempsey AF, Oliver K. Initiating Human Papillomavirus Vaccination at Age 9: Strategies for Success From 5 US Health Systems. Acad Pediatr. 2025 Sep-Oct; 25(7):102869.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|